These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35156834)

  • 1. Improving Equitable Access to Continuous Glucose Monitors for Alabama's Children with Type 1 Diabetes: A Quality Improvement Project.
    Schmitt J; Fogle K; Scott ML; Iyer P
    Diabetes Technol Ther; 2022 Jul; 24(7):481-491. PubMed ID: 35156834
    [No Abstract]   [Full Text] [Related]  

  • 2. Disparities in Hemoglobin A1c Levels in the First Year After Diagnosis Among Youths With Type 1 Diabetes Offered Continuous Glucose Monitoring.
    Addala A; Ding V; Zaharieva DP; Bishop FK; Adams AS; King AC; Johari R; Scheinker D; Hood KK; Desai M; Maahs DM; Prahalad P;
    JAMA Netw Open; 2023 Apr; 6(4):e238881. PubMed ID: 37074715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study.
    DeSalvo DJ; Noor N; Xie C; Corathers SD; Majidi S; McDonough RJ; Polsky S; Izquierdo R; Rioles N; Weinstock R; Obrynba K; Roberts A; Vendrame F; Sanchez J; Ebekozien O
    J Diabetes Sci Technol; 2023 Mar; 17(2):322-328. PubMed ID: 34632823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study.
    Sheikh K; Bartz SK; Lyons SK; DeSalvo DJ
    J Diabetes Res; 2018; 2018():5162162. PubMed ID: 30151393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in Psychosocial Outcomes in Children with Type 1 Diabetes and Their Parents Following Subsidy for Continuous Glucose Monitoring.
    Burckhardt MA; Abraham MB; Mountain J; Coenen D; Paniora J; Clapin H; Jones TW; Davis EA
    Diabetes Technol Ther; 2019 Oct; 21(10):575-580. PubMed ID: 31335192
    [No Abstract]   [Full Text] [Related]  

  • 6. The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND Randomized Clinical Trial.
    Polonsky WH; Hessler D; Ruedy KJ; Beck RW;
    Diabetes Care; 2017 Jun; 40(6):736-741. PubMed ID: 28389582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes.
    Mulinacci G; Alonso GT; Snell-Bergeon JK; Shah VN
    Diabetes Technol Ther; 2019 Jan; 21(1):6-10. PubMed ID: 30575413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of continuous glucose monitoring in youth with type 1 diabetes aged 15-21 years.
    Lee MA; Holmes-Walker DJ; Farrell K; Clark-Luccitti A
    Intern Med J; 2023 Feb; 53(2):209-215. PubMed ID: 33949770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Technology in Underserved Adults With Type 1 Diabetes: Effect of Diabetes Practice Transformations on Improving Equity in CGM Prescribing Behaviors.
    Mathias P; Mahali LP; Agarwal S
    Diabetes Care; 2022 Oct; 45(10):2231-2237. PubMed ID: 36054022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Medicaid Patients With Type 1 Diabetes Benefit From Continuous Glucose Monitor Technology.
    Ravi SJ; Coakley A; Vigers T; Pyle L; Forlenza GP; Alonso T
    J Diabetes Sci Technol; 2021 May; 15(3):630-635. PubMed ID: 32172603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring.
    Lanzinger S; Best F; Bergmann T; Laimer M; Lipovsky B; Danne T; Zimny S; Bramlage P; Meyhöfer S; Holl RW
    Diabetes Technol Ther; 2022 Oct; 24(10):763-769. PubMed ID: 35653726
    [No Abstract]   [Full Text] [Related]  

  • 13. Disparities in Continuous Glucose Monitoring Use Among Women of Reproductive Age with Type 1 Diabetes in the T1D Exchange.
    Venkatesh KK; Powe CE; Buschur E; Wu J; Landon MB; Gabbe S; Gandhi K; Grobman WA; Fareed N
    Diabetes Technol Ther; 2023 Mar; 25(3):201-205. PubMed ID: 36753706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Continuous Glucose Monitoring Uptake in Underserved Youth with Type 1 Diabetes: The IMPACT Study.
    Lin T; Manfredo JA; Illesca N; Abiola K; Hwang N; Salsberg S; Akhtar Y; Mathioudakis N; Brown EA; Wolf RM
    Diabetes Technol Ther; 2023 Jan; 25(1):13-19. PubMed ID: 36223197
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of do-it-yourself real-time continuous glucose monitoring on psychological and glycemic variables in children with type 1 diabetes: A randomized crossover trial.
    Elbalshy MM; Styles S; Haszard JJ; Galland BC; Crocket H; Jefferies C; Wiltshire E; Tomlinson P; de Bock MI; Wheeler BJ
    Pediatr Diabetes; 2022 Jun; 23(4):480-488. PubMed ID: 35253331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes Technology Use in Remote Pediatric Patients with Type 1 Diabetes Using Clinic-to-Clinic Telemedicine.
    Cobry EC; Reznick-Lipina T; Pyle L; Slover R; Thomas JF; Alonso GT; Wadwa RP
    Diabetes Technol Ther; 2022 Jan; 24(1):67-74. PubMed ID: 34524007
    [No Abstract]   [Full Text] [Related]  

  • 20. Exploring Parental Experiences of Using a Do-It-Yourself Solution for Continuous Glucose Monitoring Among Children and Adolescents With Type 1 Diabetes: A Qualitative Study.
    Elbalshy M; Boucher S; Crocket H; Galland B; MacKenzie C; de Bock MI; Jefferies C; Wiltshire E; Wheeler BJ
    J Diabetes Sci Technol; 2020 Sep; 14(5):844-853. PubMed ID: 31875411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.